STC2 and glioblastoma: The results indicated that expression level of STC2 was significantly correlated with MMRs in almost all cancers except BLCA, cholangiocarcinoma (CHOL), DLBC, glioblastoma multiforme (GBM), KICH, LAML, and SARC.